loading page

Analysis of Seasonal H3N2 Influenza Virus Epidemic Characteristics and Whole Genome Features in Jining City from 2018 to 2023
  • +8
  • Yajuan Jiang,
  • Huixin Dou,
  • Xiaoyu Wang,
  • Tongyun Song,
  • Yongjian Jia,
  • Ying Yue,
  • Libo Li,
  • * Feifei,
  • Yu-Min Liang,
  • Bo-Yan Jiao,
  • Baihai Jiao
Yajuan Jiang
Centers for Disease Control and Prevention Global Health China
Author Profile
Huixin Dou
Centers for Disease Control and Prevention Global Health China
Author Profile
Xiaoyu Wang
Centers for Disease Control and Prevention Global Health China
Author Profile
Tongyun Song
Jiangxi Maternal and Child Health Hospital Department of Oncology
Author Profile
Yongjian Jia
Centers for Disease Control and Prevention Global Health China
Author Profile
Ying Yue
Centers for Disease Control and Prevention Global Health China
Author Profile
Libo Li
Centers for Disease Control and Prevention Global Health China
Author Profile
* Feifei
Northern Arizona University
Author Profile
Yu-Min Liang
Centers for Disease Control and Prevention Global Health China
Author Profile
Bo-Yan Jiao
Centers for Disease Control and Prevention Global Health China

Corresponding Author:j198319831983@126.com

Author Profile
Baihai Jiao
University of Connecticut School of Medicine
Author Profile

Abstract

Background: Seasonal H3N2 influenza virus, known for its rapid evolution, poses a serious threat to human health. This study focuses on analyzing the influenza virus trends in Jining City (2018-2023) and understanding the evolving nature of H3N2 strains. Methods: Data on influenza-like cases was gathered from Jining City’s sentinel hospitals: Jining First People’s Hospital and Rencheng Maternal and Child Health Hospital, using the Chinese Influenza Surveillance Information System. Over the period from 2018 to 2023, 7,844 throat swab specimens were assessed using real-time fluorescence quantitative PCR for influenza virus nucleic acid detection. For cases positive for seasonal H3N2 influenza virus, virus isolation was followed by whole genome s
Submitted to Journal of Medical Virology
03 Apr 2024Review(s) Completed, Editorial Evaluation Pending
06 Apr 2024Reviewer(s) Assigned
30 Apr 2024Editorial Decision: Revise Major
03 Jun 20241st Revision Received
06 Jun 2024Assigned to Editor
06 Jun 2024Submission Checks Completed
06 Jun 2024Review(s) Completed, Editorial Evaluation Pending
20 Jun 2024Reviewer(s) Assigned
04 Jul 2024Editorial Decision: Revise Minor
09 Jul 20242nd Revision Received
09 Jul 2024Review(s) Completed, Editorial Evaluation Pending
14 Jul 2024Reviewer(s) Assigned
23 Jul 2024Editorial Decision: Accept